We are live on
!
Find out more
BI
Boulegeris Investments Portfolio holdings
AUM
$200M
1-Year Est. Return
7%
This Fund
S&P 500
This Quarter
Est. Return
+4.49%
1 Year Est. Return
+7%
3 Year Est. Return
+39.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$136M
AUM Growth
+$10.1M
(+8%)
Cap. Flow
+$5.81M
Cap. Flow
% of AUM
4.28%
Top 10 Holdings %
Top 10 Hldgs %
62.09%
Holding
51
New
6
Increased
24
Reduced
15
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.96M |
| 2 |
Walt Disney
DIS
|
+$1.09M |
| 3 |
DHC
Diversified Healthcare Trust
DHC
|
+$754K |
| 4 |
Biogen
BIIB
|
+$618K |
| 5 |
Home Depot
HD
|
+$612K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Acadia Pharmaceuticals
ACAD
|
+$1.93M |
| 2 |
Johnson & Johnson
JNJ
|
+$1.02M |
| 3 |
Procter & Gamble
PG
|
+$635K |
| 4 |
Lockheed Martin
LMT
|
+$617K |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$511K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.5% |
| 2 | Real Estate | 23.19% |
| 3 | Technology | 11.57% |
| 4 | Consumer Staples | 7.58% |
| 5 | Financials | 5.73% |
Similar funds
ACM
SSM
PCM
OA
XGI
MGA
MFP
ESG
Boulegeris Investments's Q1 2015 Portfolio in Review
As of Q1 2015, Boulegeris Investments held 51 positions worth $136M, up 8% from $126M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Boulegeris Investments deployed $5.81M of net new capital in Q1 2015, opening 6 new positions and adding to 24 existing holdings. Its largest new stake was Allergan plc: 13,886 shares worth $4.13M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Real Estate and Technology.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.02M trimmed.
- Boulegeris Investments's largest Q1 2015 buy was Allergan plc: 13,886 shares worth $4.13M.
- Boulegeris Investments added most to Walt Disney in Q1 2015, an estimated $1.09M increase.
- Boulegeris Investments's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $1.02M.
- Boulegeris Investments fully exited Acadia Pharmaceuticals in Q1 2015, selling an estimated $1.93M.
- Boulegeris Investments's ten largest holdings make up 62% of its $136M portfolio in Q1 2015.
- Boulegeris Investments opened 6 new positions and closed 3 in Q1 2015.
- Boulegeris Investments's portfolio value rose 8% quarter-over-quarter to $136M.
Based on Boulegeris Investments's 13F filing for Q1 2015, filed 12 May 2015.